Again, you missed the point of my question. Al Mann was unable to make Afrezza a success and he had as many if not more connections than David Kendall plus a billion dollars. Afrezza is a great drug but the other big pharma companies that are in cahoots with big insurance will do all it can to protect their monopoly. My opinion that David might convince a few doctors to start Rxing Afrezza.
But, unless the medical profession, ie ENDOs, open up their thick skulls and realize they need to re-educate themselves AND have insurance companies go against their profit motive tendencies that allow them to get money from BP who sell them their liquid insulin to then start approving Afrezza as the first Insulin, Afrezza will never catch on and sell enough in the US to break even.
The deck has been and always will be stacked against Mannkind.
So make money trading the stock.
Market Data 
Markets 
AI
